FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models. [electronic resource]
Producer: 20120518Description: 396-404 p. digitalISSN:- 1873-7544
- Adaptor Proteins, Signal Transducing
- Animals
- Benzeneacetamides -- pharmacology
- Blotting, Western
- Cell Line
- Chromones -- pharmacology
- Corpus Striatum -- drug effects
- DNA-Binding Proteins -- biosynthesis
- Dopamine -- metabolism
- Dopaminergic Neurons -- drug effects
- Flow Cytometry
- Immunohistochemistry
- Immunoprecipitation
- MPTP Poisoning -- drug therapy
- Male
- Mice
- Mice, Inbred C57BL
- Morpholines -- pharmacology
- Movement Disorders -- drug therapy
- Neuroprotective Agents
- Oncogene Protein v-akt -- physiology
- Phenols -- pharmacology
- Postural Balance -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Signal Transduction -- drug effects
- TOR Serine-Threonine Kinases -- physiology
- Transcription Factors -- biosynthesis
- Tyrosine 3-Monooxygenase -- metabolism
- alpha-Synuclein -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.